tldrdaily.news logo
Tag

Vertex

All articles tagged with #vertex

finance5 months ago

Market Highlights: Palantir and Hims Lead After-Hours Gains

Stock futures rose as markets gained optimism for a September rate cut. Palantir surged 5.3% after strong Q2 earnings and raised full-year guidance, while Vertex fell 16% due to a failed drug trial. Hims & Hers dropped 13% amid lower-than-expected profits, and other companies like DuPont and Axon reported mixed results. BP and AMD showed positive movements, with BP exceeding profit expectations and AMD preparing to report earnings. Several other companies are set to release earnings today.

via Barron's|
#earnings-report#finance#hims-and-hers
business5 months ago

Vertex Shares Drop 15% After Pain Drug Phase 2 Failure

Vertex Pharmaceuticals' stock dropped over 14% after the company announced it would not proceed with further testing of its pain drug VX-993 following disappointing midstage trial results, impacting its pain franchise. Despite beating quarterly sales and profit expectations driven by other products, the setback highlights challenges in expanding its pain treatment portfolio. The company also announced the retirement of its CSO, with a transition planned for early next year.

via Investor's Business Daily|
#biotech#business#journavx
business-healthcare1 year ago

"Vertex Pharmaceuticals' $4.9B Acquisition of Alpine Expands Focus to Kidney and Autoimmune Diseases"

Vertex Pharmaceuticals has announced a $4.9 billion deal to acquire Alpine Immune Sciences and its experimental drug povetacicept, aimed at treating IgA nephropathy, a kidney disease. The acquisition will expand Vertex's work in kidney and autoimmune diseases, marking a significant investment from the biotech company.

via Endpoints News|
#acquisition#alpine-immune-sciences#autoimmune-disease
stock-market2 years ago

Jim Cramer's Lightning Round: Vertex, Columbia Sportswear, Palantir, Upstart, Nvidia - A Stock Analysis

Jim Cramer, host of CNBC's "Mad Money," shared his thoughts on various stocks during his lightning round segment. He praised Vertex as an "excellent" company, while expressing skepticism towards BlackBerry and Under Armour. Cramer recommended holding off on buying more Shopify shares and suggested considering Kyndryl as a potential winner in the market.

via CNBC|
#blackberry#kyndryl#sabre